Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: FTSE (1.8%), DAX (4.9%), CAC (3.6%), IBEX (3.2%), MIB (3.4%)

Apr 07 ,2025

  • Synopsis

    • European equity markets indicated to open lower, extending last week's heavy losses that saw STOXX Europe 600 slump (8.4%) as markets reacted negatively to US President Trump's "Liberation Day" reciprocal tariffs. In the US, it was also the worst week for the S&P 500, Nasdaq, and Russell 2000 since Mar-20. S&P 500 and Nasdaq futures down another 3-4%.

    • Asian equities seeing steep losses Monday. Hang Seng (11.8%) leading heavy declines across China markets with tech sector down (16%). Taiwan also in bear market with TSMC limit down. Nikkei circuit breaker triggered before open, though off worst levels. ASX and Kospi also down sharply. Recall there was a flurry of China announcements in response to last week's reciprocal tariffs. Main headline was a 34% tariff on US imports effective 10-Apr with no exemptions. China stimulus expectations rise with tariffs weighing on growth and earnings outlook.

    • Trade war fears continue to overhang markets. No signs of de-escalation from weekend tariff headlines with Trump and White House officials dismissing market volatility. Multiple countries voicing willingness to talk with some offering trade concessions. However, unclear whether it will be enough with Trump again talking about tariffs as structural measure to rebalance trade and provide new source of government funding.

    • European macro data releases out today include Germany Feb trade balance, Norway Feb manufacturing production, UK Mar house price index - Halifax, Eurozone Apr investor confidence - Sentix, Feb retail sales

    • In central banks, Bank of Italy's Scotti speech at 9:50CET at the conf (through Tue) on "The interplay between tax and financial regulations in a new digital environment", panellists include ECB's Cipollone at 11:45. In politics, meeting of EU Foreign Council on Trade. Polish President Duda pays 3-day visit to Estonia (through Wed). Norway's minister of defense Sandvik has a bilateral meeting with Iceland's minister of foreign affairs Gunnarsdóttir. In UK, MPs hold a general debate on road maintenance, whilst committee topics include work of the Dept. for Business and Trade at 15:00BST. EU's Kallas begins a 2-day trip in Montenegro, then too Albania, Bosnia and Herzegovina on Tue. With six weeks to go until Portugal's general election, tv debates kick-off on TVI at 21:00CET (Montenegro (AD) x Raimundo (CDU)) and RTP3 at 22:00 (Ventura (Chega) x Real (PAN)).

  • Politics/Macro/World News

    • Trump tariffs risk large euro-area 'demand shock', central banker warns -- FT

    • France suggests targeting Big Tech's data use in response to US tariffs -- POLITICO

    • Starmer Vows Steps to Bolster UK Business Against Tariff Threat -- Bloomberg

    • ECB's Schnabel Says Trump's Onslaught May Mark End of Free Trade -- Bloomberg

    • China Discusses Accelerating Stimulus to Counter Trump Tariffs -- Bloomberg

    • Bill Ackman warns Trump is losing business leaders' confidence -- Reuters

    • EV targets watered down to help tariff-hit UK car industry -- FT

  • Top company news

    • Earnings/updates

      • AKRBP.NO (Aker BP) -- reports Q1 net production 441.4 mboepd vs quarter-ago 449.2

      • LSG.NO (Lerøy Seafood Group) -- issues Q1 trading update; total harvest volume of salmon and trout (ex-Scottish Seafarm, GWT) 38.2K vs year-ago 26.4K

      • HAUTO.NO (Höegh Autoliners) -- March trading update: transported 1.3M cbm of cargo on prorated basis

      • CLAS.B.SS (Clas Ohlson) -- reports Mar sales +17% to SEK814M; +19% organic

      • AV.IM (Antares Vision) -- presents 2025-27 business plan; targets adj. EBITDA margin between 20-21% in 2027

      • Also reporting today

        • Trading Update: Repsol (REP.SM), Shell (SHEL.LN)

        • CMD/events: ACOMO (ACOMO.NA), Ion Beam Applications (IBAB.BB)

    • M&A

      • SRT3.GR (Sartorius) -- Sartorius to acquire microtissue business MatTek from BICO AB for $80M (~€72M)

      • ENGI.FP (ENGIE) -- EVSE to acquire Engie's EV fast-charging business in Australia and New Zealand - Australian Financial PSM.GR (ProSiebenSat.1 Media) -- ProSiebenSat.1 lines up defence advisers amid takeover bid from MFE-MediaForEurope - Reuters

      • AZE.BB (Azelis Group) -- acquires 100% of shares of Solchem Nature S.L. in Spain; terms undisclosed

      • BSGR.NA (B&S Group) -- divests Lagaay Medical Group and non-strategic liquor activities (

      • ANIM.IM (Anima Holding SpA) -- Banco BPM offer for Anima Holding SpA reaches 89.94%

      • DEZ.GR (Deutz AG) -- to acquire UMS; terms not disclosed

      • DLAR.LN (De La Rue) -- close to concluding £300M sale of authentication arm to Crane NXT - Sky News

      • BICO.SS (BICO Group) -- BICO to divest MatTek to Sartorius for $80M

      • Multiple factors behind negative sentiment in data centre space - The Australian

    • Healthcare

      • BAYN.GR (Bayer AG) -- announces filing of petition to US Supreme Court for review of Durnell Roundup case

      • RYTM (Rhythm Pharmaceuticals) -- to host call on 7-Mon at 8:00 ET; announce topline results from pivotal Phase 3 TRANSCEND trial evaluating setmelanotide in patients with acquired hypothalamic obesity

      • BIM.FP (bioMerieux) -- obtains CE-marking of LUMED APSS, an advanced clinical decision support system designed to enhance antimicrobial stewardship programs and improve patient outcomes

      • YPSN.SW (Ypsomed Holding) -- Ypsomed and Sidekick Health launch a collaborative digital health solution for obesity management

    • Other

      • ERIC.B.SS (Telefonaktiebolaget LM Ericsson) -- SEC filing: SCHEDULE 13D/A (Filed by INVESTOR AB)

      • AIR.FP (Airbus SE) -- EVA Airways places firm order for six A350-1000s, three A321neos

      • RWE.GR (RWE) -- won government development consent for 1.2GW Rampion 2 wind project off UK coast

      • TKA.GR (ThyssenKrupp) -- s to terminate the supply contract with Hüttenwerke Krupp Mannesmann

      • ABF.LN (Associated British Foods) -- Issues at Primark could lead to spinoff from Associated British Foods - Mail on Sunday

      • SREN.SW (Swiss Re) -- to be appointed as co-investment manager of GAM's catastrophe bond and ILS fund range

      • G.IM (Assicurazioni Generali) -- ISS recommends Generali investors vote to give CEO Philippe Donnet another term at 24-Apr general meeting - Reuters

      • TGS.NO (TGS-NOPEC Geophysical Co.) -- secures OBN 3D contract offshore Trinidad

      • Estimated weekend box office revenues in US, Canada $195.8M, +128.9% y/y - Box Office Mojo

      • Executive compensation and living wages at UK retailers targets of recent shareholder resolutions (4-Apr)

      • Howmet Aerospace declares force majeure; may halt shipments due to Trump tariffs - Reuters

      • Large institutional investors evaluating options to discard stakes in illiquid private equity funds following market rout - FT

  • Key rating changes

    • Upgrades

      • SAVE.SS (Nordnet) -- to buy from hold at Pareto

    • Downgrades

      • AUTO.NO (AutoStore Holdings) -- to neutral from buy at Citi

      • NOD.NO (Nordic Semiconductor) -- to hold from buy at Pareto

      • TEL.NO (Telenor) -- to hold from buy at Pareto

      • BNP Paribas Exane downgrades ACX.SM, APAM.NA

    • Both

      • Barclays upgrades MNDI.LN; downgrades HOLM.B.SS, STERV.FH

  • Data

    • Nikkei (6.76%) to 31497.98

    • Hang Seng (11.83%) to 20147.15

    • Shanghai Composite (7.08%) to 3105.47

    • S&P futures (178.0) vs prior close of 5110.3

    • €-$ +0.0124 or +1.14% to 1.1010

    • $-¥ +0.25 or +0.17% to 145.73

    • €-¥ +2.11 or +1.33% to 160.44

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE